🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07668648
Recruiting Not applicable

Interscalene Brachial Plexus Block Versus Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery

NCT07668648 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-06-25
Last updated
2026-06-29

Condition(s) studied

Postoperative PainShoulder Arthroscopy

Investigational drug(s) / intervention(s)

Interscalene Brachial Plexus BlockSerratus Posterior Superior Intercostal Plane BlockBupivacaine →

Interscalene Brachial Plexus Block: Ultrasound-guided interscalene brachial plexus block performed before induction of general anesthesia for postoperative analgesia in arthroscopic shoulder surgery.

Serratus Posterior Superior Intercostal Plane Block: Ultrasound-guided serratus posterior superior intercostal plane block performed before induction of general anesthesia for postoperative analgesia in arthroscopic shoulder surgery.

Bupivacaine: Bupivacaine administered for ultrasound-guided regional anesthesia block.

Study summary

Arthroscopic shoulder surgery is associated with moderate to severe postoperative pain that may delay recovery and rehabilitation. Interscalene brachial plexus block (ISB) is widely used for postoperative analgesia in shoulder surgery; however, it may be associated with complications such as phrenic nerve paralysis. The serratus posterior superior intercostal plane (SPSIP) block is a recently described fascial plane block that may provide effective analgesia while avoiding some of the limitations of ISB.

This prospective, randomized, double-blind controlled trial aims to compare the analgesic efficacy of ISB and SPSIP block in patients undergoing elective arthroscopic shoulder surgery under general anesthesia. The primary outcome is total postoperative opioid consumption during the first 24 hours after surgery. Secondary outcomes include postoperative pain scores, quality of recovery, time to first rescue analgesia, rescue analgesic requirements, intraoperative opioid consumption, sensory block distribution, motor block characteristics, and block-related complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 18 and 75 years * ASA physical status I, II, or III * Scheduled for elective arthroscopic shoulder surgery under general anesthesia * Provision of written informed consent Exclusion Criteria: * Refusal to participate in the study * Coagulopathy * Current anticoagulant therapy * Infection at the block site * Previous surgery involving the planned block site * Known allergy or history of toxicity to local anesthetics * Hepatic failure * Renal failure * Uncontrolled diabetes mellitus * Cognitive impairment or mental disability preventing reliable assessment * Chronic opioid use or ongoing chronic pain treatment * Pregnancy, suspected pregnancy, or breastfeeding * Chronic pulmonary disease (e.g., COPD or asthma) * Failed block

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bursa City Hospital Bursa Nilüfer Recruiting

More Ferit Yetik trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07668648 on ClinicalTrials.gov ↗ ← All trials in Turkey